Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

3,476

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

3,476 results for “Parkinsons Disease”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov36/100

Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation

ClinicalTrials.gov study NCT03047629. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease

ClinicalTrials.gov study NCT00660673. IPD Sharing: YES. Countries: 11. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease

ClinicalTrials.gov study NCT02230904. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
dryad36/100

Data for: Deep brain stimulation in early-stage Parkinson disease

Open the record for dataset details and reuse information.

publicFeb 2023View details →
dryad36/100

Pain coping strategies and their association with quality of life in people with Parkinson's Disease: a Cross-Sectional study

Open the record for dataset details and reuse information.

publicJul 2021View details →
dryad36/100

A blinded, controlled trial of objective measurement in Parkinson’s disease

Open the record for dataset details and reuse information.

publicJun 2021View details →
dryad36/100

The reaction mechanism for glycolysis side product degradation by Parkinson's disease-linked DJ-1

Open the record for dataset details and reuse information.

publicJun 2025View details →
dryad36/100

Data from: Movement-responsive deep brain stimulation for Parkinson’s Disease using a remotely optimized neural decoder

Open the record for dataset details and reuse information.

publicApr 2025View details →
dryad36/100

Enhanced mTORC1 signaling and protein synthesis in pathologic alpha-synuclein cellular and animal models of Parkinson’s disease

Open the record for dataset details and reuse information.

publicNov 2023View details →
dryad36/100

Parkinson’s disease-associated, sex-specific changes in DNA methylation at PARK7 (DJ-1), ATXN1, SLC17A6, NR4A2, and PTPRN2 in cortical neurons

Open the record for dataset details and reuse information.

publicJun 2022View details →
dryad36/100

Data from: Decreased cerebrospinal fluid orexin levels not associated with clinical sleep disturbance in Parkinson’s disease: A retrospective study

Open the record for dataset details and reuse information.

publicJan 2023View details →
dryad36/100

A five-sensor IMU-based Parkinson's disease patient and control dataset including three activities of daily living

Open the record for dataset details and reuse information.

publicAug 2023View details →
dryad36/100

Barriers to home exercise for patients with Parkinson’s disease – a qualitative study

Open the record for dataset details and reuse information.

publicJan 2023View details →
dryad36/100

Data from: Vocal and tongue exercise in early to mid-stage Parkinson disease using the Pink1-/- rat

Open the record for dataset details and reuse information.

publicNov 2024View details →
dryad36/100

Extended data for behavioural change for Parkinson’s disease: A randomised controlled feasibility study to promote physical activity and exercise adherence among people with Parkinson’s, study protocol

Open the record for dataset details and reuse information.

publicMay 2024View details →
dryad36/100

Data from: Developmental exposure to the Parkinson’s disease-associated organochlorine pesticide dieldrin alters dopamine neurotransmission in α-synuclein pre-formed fibril (PFF)-injected mice

Open the record for dataset details and reuse information.

publicAug 2023View details →
dryad36/100

Developmental dieldrin exposure alters DNA methylation at genes related to dopaminergic neuron development and Parkinson’s disease in mouse midbrain

Open the record for dataset details and reuse information.

publicJan 2020View details →
dryad36/100

Parkin regulates amino acid homeostasis at mitochondria-lysosome (M/L) contact sites in Parkinson’s disease

Open the record for dataset details and reuse information.

publicMay 2023View details →
dryad36/100

The c-Abl inhibitor IkT-148009 therapeutically suppresses neurodegeneration in models of heritable and sporadic Parkinson’s Disease

Open the record for dataset details and reuse information.

publicDec 2022View details →
dryad32/100

Data from: Blood NfL: a biomarker for disease severity and progression in Parkinson's disease

Objective: To examine whether plasma neurofilament light chain (NfL) levels were associated with motor and cognitive progression in Parkinson's disease (PD). Methods: This prospective follow-up study enrolled 178 participants, including 116 with PD, 22 with multiple system atrophy (MSA), and 40 healthy controls. We measured plasma NfL levels with electrochemiluminescence immunoassay. Patients with PD received evaluations of motor and cognition, at baseline and at a mean follow-up interval of 3 years. Changes in the unified Parkinson's disease rating scale (UPDRS) part III motor score and Mini-Mental State Examination (MMSE) score were used to assess motor and cognition progression. Results: Plasma fL levels were significantly higher in MSA than in PD and healthy groups (35.8±6.2 pg/ml, 17.6±2.8 pg/ml, and 10.6±2.3 pg/ml, respectively; P<0.001). In the PD group, NfL levels were significantly elevated in patients with advanced Hoehn-Yahr (H-Y) stage and patients with dementia (PDD) (P<0.001). NfL levels were modestly correlated with UPDRS part III scores (r=0.42, 95% CI: 0.46-0.56, P<0.001). After a mean follow-up of 3.4±1.2 years, a Cox regression analysis adjusted for age, sex, disease duration and baseline motor or cognitive status showed that higher baseline NfL levels were associated with higher risks for either motor or cognition progression (P=0.029 and P=0.015, respectively). Conclusions: Plasma NfL levels correlated with disease severity and progression in terms of both motor and cognitive functions in PD. Classification of evidence: This study provides Class III evidence that plasma NfL levels distinguish PD and MSA, and is a surrogate biomarker for PD progression.

opencc-zeroJun 2020View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record